Find therapies in clinical trials near you – page 594

Study on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease

Study on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease

Study of LY3295668 Erbumine for Patients with Relapsed or Refractory Neuroblastoma

Study of LY3295668 Erbumine for Patients with Relapsed or Refractory Neuroblastoma

Study on Liver Cancer in Cirrhosis Patients Using Idarubicin and Lipiodol Injection

Study on Liver Cancer in Cirrhosis Patients Using Idarubicin and Lipiodol Injection

Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Study of venetoclax and azacitidine combination treatment for acute myeloid leukemia patients with measurable residual disease after chemotherapy or before stem cell transplant

Study of venetoclax and azacitidine combination treatment for acute myeloid leukemia patients with measurable residual disease after chemotherapy or before stem cell transplant

Study on Sodium Zirconium Cyclosilicate for Improving Heart Failure Treatment in Patients with High-Risk Hyperkalemia

Study of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Study of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Study on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy

Study on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy

Study on Allergy to Lepidoglyphus Destructor: Testing with Lepidoglyphus Destructor Extract, Histamine Hydrochloride, and Sodium Chloride in Affected Patients

Study on Allergy to Lepidoglyphus Destructor: Testing with Lepidoglyphus Destructor Extract, Histamine Hydrochloride, and Sodium Chloride in Affected Patients